percentage of patients receiving pharmacotherapy to treat this condition is still very small. Naltrexone is a mu opioid antagonist that is posited to reduce the neurobiological reward obtained from alcohol ... causing…
Naltrexone is an opioid receptor antagonist with FDA approval for treating opioid addiction since 1984. While typical dose for treating opioid addiction with naltrexone is between ... dose naltrexone (LDN) with doses…
dose naltrexone (LDN) can modulate CNS microglial cells and is being used as an experimental treatment to reduce inflammatory autoimmune processes in a number of diseases, including fibromyalgia. Additionally…
Background: Buprenorphine is a partial mu-opioid agonist and kappa antagonist, whereas Naltrexone is a competitive μ receptor antagonist. Buprenorphine’s partial agonist activity can induce withdrawal in opioid…
Objective: The opioid antagonist naltrexone has been proven as an efficacious treatment for alcoholism. However, in clinical trials the reported medication adherence has often been poor, being ... problems associated…
days with an SGA olanzapine, a combination of olanzapine and an opioid receptor antagonist, naltrexone, naltrexone alone or vehicle, and their food consumption and body weight were measured daily ... first nine days and…
comprising capsules filled with pellets of extended-release oxycodone hydrochloride, an opioid, surrounding sequestered naltrexone hydrochloride, an opioid antagonist. This study compared oxycodone pharmacokinetics…
production of various cytokines in rats. Furthermore, the experimental results demonstrate that naltrexone, an opiate receptor antagonist, may prevent the suppressive effect of alcohol on immune functions. Recent data…
This work establishes a simple method for the determination of naltrexone by chemiluminescence (CL) technique. This method is based on the enhancement effect of naltrexone on the weak CL emission ... Under the optimum…
Background: Our study was aimed to know does Naltrexone used in opioid dependent patient have any relation with the onset of depression. Methods: Naltrexone was given to 30 opioid dependent ... psychiatric comorbidity…
Three oral pharmacotherapies (acamprosate, disulfiram, and naltrexone) are commonly used for the management of alcohol abuse or dependence. Naltrexone is an opioid antagonist which primarily, but not exclusively…
Background: It is well known that naltrexone, an FDA-approved medication for treatment of alcohol dependence, is effective for only a subset of individuals. Recent studies have examined the utility ... nucleotide…
sensitive, rapid, accurate and selective spectrοphͻtometric estimation of naltrexone in large mass and in dͻsage fͻrms. This reaction depends on the conversion of primary amine of phentermine with hydrοchloric acid…
celiac disease patient with diet refractory dermatitis herpetiformis was treated with low dose naltrexone. Randomized controlled trials showed that this short acting opioid antagonist is effective therapy in Crohn…
Oral naltrexone has been used effectively to manage problem opiate and alcohol use but patient noncompliance limits its utility. Over the past decade an increasing body of research has suggested ... that the use of…
practitioners involved in the care of opioid dependent patients with a special reference to Naltrexone. Materials & Methods: Relevant literature was identified through a PubMed literature search for publications…
Naltrexone has been observed to have both a stimulatory and inhibitory effect on the development of tumours in rodents, potentially mediated by changes to the neuroendocrine system as a result ... study examined the…
Currently, the obesity menace is mainly confronted by the administration of a commercially available naltrexone/bupropion tablet formulation (Mysimba®), the use of which is, though, not devoid of serious side…
opioid growth factor (OGF) – OGF receptor (OGFr) axis by low dosages of naltrexone (LDN) as a disease modifying therapy using a mouse model of relapse-remitting experimental autoimmune encephalomyelitis ... After two…
phase high performance liquid chromatographic method has been developed for the quantitative estimation of Naltrexone Hydrochloride (NAL) in bulk drug and its formulation dosage forms using column oyster
Background: Naltrexone is an orally active opioid agonist that has the potential for use as a t reat ment option for opiat e addict ion. However, in order
simple, specific and accurate RP-HPLC method was developed for the simultaneous analysis of Naltrexone hydrochloride (NTX) and Bupropion hydrochloride (BUP) in bulk and dosage forms. A Phenomenex C18 column
health concern. In contrast to opioid μ-agonist (or ‘substitution’) maintenance treatments, injectable extendedrelease naltrexone (XR‑NTX), approved in the USA and Russia, is an opioid antagonist, formulated to address…
dose naltrexone (LDN) can modulate CNS microglial cells and is being used as an experimental treatment to reduce inflammatory autoimmune processes in a number of diseases, including fibromyalgia. Additionally…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.